Completed PHASE4 INTERVENTIONAL 5-arm NCT04026074

Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.

Randomized Controlled Doubleblind Pilot Study Comparing Analgosedation Concepts During Placement of Regional Anaesthesia With Either Fentanyl, Remifentanil, Clonidine, EMLA-Patch or Placebo in Regard of Pain Reduction.

Sponsor: Medical University of Graz

Conditions Fractures, Closed Hip Arthritis Knee Arthropathy

Interventions Clonidine EMLA Cream Fentanyl Placebo iv Placebo salve Remifentanil

Updated 6 times since 2019 Last updated: Oct 18, 2019 Started: Jul 26, 2019 Primary completion: Oct 16, 2019 Completion: Oct 18, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04026074, this PHASE4 trial focuses on Fractures, Closed and Hip Arthritis and remains completed. Sponsored by Medical University of Graz, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Oct 2019 — Nov 2019 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Aug 2019 — Oct 2019 [monthly]

Recruiting PHASE4

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria